These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 23786316)

  • 1. Stochastic model for estimating the risk of transfusion-transmitted hepatitis B in Vietnam.
    Viet L; Husebekk A; Husum H; Skjerve E
    Transfus Med; 2013 Dec; 23(6):423-31. PubMed ID: 23786316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occult hepatitis B virus infection: implications in transfusion.
    Allain JP
    Vox Sang; 2004 Feb; 86(2):83-91. PubMed ID: 15023176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
    Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
    Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-HBc & HBV-DNA detection in blood donors negative for hepatitis B virus surface antigen in reducing risk of transfusion associated HBV infection.
    Behzad-Behbahani A; Mafi-Nejad A; Tabei SZ; Lankarani KB; Torab A; Moaddeb A
    Indian J Med Res; 2006 Jan; 123(1):37-42. PubMed ID: 16567866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B virus DNA-positive, hepatitis B surface antigen-negative blood donations intercepted by anti-hepatitis B core antigen testing: the Canadian Blood Services experience.
    O'Brien SF; Fearon MA; Yi QL; Fan W; Scalia V; Muntz IR; Vamvakas EC
    Transfusion; 2007 Oct; 47(10):1809-15. PubMed ID: 17880605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occult Hepatitis B virus infection in previously screened, blood donors in Ile-Ife, Nigeria: implications for blood transfusion and stem cell transplantation.
    Olotu AA; Oyelese AO; Salawu L; Audu RA; Okwuraiwe AP; Aboderin AO
    Virol J; 2016 May; 13():76. PubMed ID: 27150469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan.
    Taira R; Satake M; Momose S; Hino S; Suzuki Y; Murokawa H; Uchida S; Tadokoro K
    Transfusion; 2013 Jul; 53(7):1393-404. PubMed ID: 23033944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors.
    Muselmani W; Habbal W; Monem F
    Transfus Med; 2013 Aug; 23(4):265-8. PubMed ID: 23621787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain.
    González R; Torres P; Castro E; Barbolla L; Candotti D; Koppelman M; Zaaijer HL; Lelie N; Allain JP; Echevarría JM
    Transfusion; 2010 Jan; 50(1):221-30. PubMed ID: 19682332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectivity of blood products from donors with occult hepatitis B virus infection.
    Allain JP; Mihaljevic I; Gonzalez-Fraile MI; Gubbe K; Holm-Harritshøj L; Garcia JM; Brojer E; Erikstrup C; Saniewski M; Wernish L; Bianco L; Ullum H; Candotti D; Lelie N; Gerlich WH; Chudy M
    Transfusion; 2013 Jul; 53(7):1405-15. PubMed ID: 23362802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occult hepatitis B virus infection: detection and significance.
    Gerlich WH; Bremer C; Saniewski M; Schüttler CG; Wend UC; Willems WR; Glebe D
    Dig Dis; 2010; 28(1):116-25. PubMed ID: 20460899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of anti-HBc screening of blood donors and its association with occult hepatitis B virus infection: Implications for blood transfusion.
    Asim M; Ali R; Khan LA; Husain SA; Singla R; Kar P
    Indian J Med Res; 2010 Sep; 132():312-7. PubMed ID: 20847378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis B core antigen and occult hepatitis B virus infections in Korean blood donors.
    Seo DH; Whang DH; Song EY; Kim HS; Park Q
    Transfusion; 2011 Aug; 51(8):1840-6. PubMed ID: 21332731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
    Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
    Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing.
    Panhotra BR; Al-Bahrani A; Ul-Hassan Z
    Saudi Med J; 2005 Feb; 26(2):270-3. PubMed ID: 15770304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Italian blood donors with anti-HBc and occult hepatitis B virus infection.
    Manzini P; Girotto M; Borsotti R; Giachino O; Guaschino R; Lanteri M; Testa D; Ghiazza P; Vacchini M; Danielle F; Pizzi A; Valpreda C; Castagno F; Curti F; Magistroni P; Abate ML; Smedile A; Rizzetto M
    Haematologica; 2007 Dec; 92(12):1664-70. PubMed ID: 18055990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A method for estimating the residual risk of transfusion-transmitted HBV infection associated with occult hepatitis B virus infection in a donor population without universal anti-HBc screening.
    Seed CR; Kiely P
    Vox Sang; 2013 Nov; 105(4):290-8. PubMed ID: 23802710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-transmitted hepatitis B virus infection.
    Candotti D; Allain JP
    J Hepatol; 2009 Oct; 51(4):798-809. PubMed ID: 19615780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor screening for hepatitis B virus infection in a cell and tissue bank.
    Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
    Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated anti-HBc-IgM antibody among blood donors in the semi-arid region of Nigeria.
    Jeremiah ZA; Idris H; Ajayi BB; Ezimah AC; Malah MB; Baba MM
    Hum Antibodies; 2011; 20(3-4):77-82. PubMed ID: 22129677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.